Gainers
- electroCore (NASDAQ:ECOR) shares increased by 27.9% to $5.47 during Friday's regular session. As of 13:30 EST, electroCore's stock is trading at a volume of 91.3K, which is 434.3% of its average full-day volume over the last 100 days. The company's market cap stands at $25.9 million.
- Concord Medical Services (NYSE:CCM) shares rose 22.72% to $1.35. The company's market cap stands at $58.6 million.
- Vicarious Surgical (NYSE:RBOT) stock moved upwards by 20.03% to $1.8. As of 13:30 EST, this security is trading at a volume of 1.4 million shares, making up 378.4% of its average full-day volume over the last 100 days. The company's market cap stands at $226.7 million.
- Virios Therapeutics (NASDAQ:VIRI) shares rose 19.61% to $0.37. Trading volume for this security as of 13:30 EST is 1.3 million, which is 357.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.7 million.
- Vaccitech (NASDAQ:VACC) shares moved upwards by 17.11% to $2.53. As of 13:30 EST, Vaccitech's stock is trading at a volume of 812.3K, which is 1535.0% of its average full-day volume over the last 100 days. The company's market cap stands at $94.3 million. As per the news, the Q4 earnings report came out today.
- ProKidney (NASDAQ:PROK) shares moved upwards by 17.07% to $12.82. The current volume of 165.1K shares is 85.0% of ProKidney's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $788.9 million.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Losers
- SQZ Biotechnologies (NYSE:SQZ) stock fell 29.9% to $0.56 during Friday's regular session. SQZ Biotechnologies's stock is trading at a volume of 1.6 million shares as of 13:30 EST. This is 518.5% of its average full-day volume over the last 100 days. The company's market cap stands at $16.5 million. The company's, Q4 earnings came out 2 days ago.
- Aptinyx (NASDAQ:APTX) shares fell 17.66% to $0.15. Trading volume for Aptinyx's stock is 25.5 million as of 13:30 EST. This is 1083.2% of its average full-day volume over the last 100 days. The company's market cap stands at $9.9 million.
- Cidara Therapeutics (NASDAQ:CDTX) stock declined by 16.79% to $1.19. As of 13:30 EST, this security is trading at a volume of 5.7 million shares, making up 191.2% of its average full-day volume over the last 100 days. The company's market cap stands at $98.4 million. As per the news, the Q4 earnings report came out yesterday.
- Bellicum Pharmaceuticals (NASDAQ:BLCM) stock decreased by 15.73% to $0.25. Bellicum Pharmaceuticals's stock is trading at a volume of 325.2K shares as of 13:30 EST. This is 364.0% of its average full-day volume over the last 100 days. The company's market cap stands at $2.1 million.
- Midatech Pharma (NASDAQ:MTP) stock fell 14.15% to $0.3. Trading volume for this security as of 13:30 EST is 92.4K, which is 176.7% of its average full-day volume over the last 100 days. The company's market cap stands at $2.0 million.
- NuCana (NASDAQ:NCNA) shares fell 13.29% to $1.24. Trading volume for NuCana's stock is 212.6K as of 13:30 EST. This is 162.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $64.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.